318 related articles for article (PubMed ID: 16862431)
21. Human parvovirus B19 in patients with aplastic anemia.
Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
[TBL] [Abstract][Full Text] [Related]
22. Detection of human parvovirus B19 in cancer patients using ELISA and real-time PCR.
Zaki SA
Indian J Med Microbiol; 2012; 30(4):407-10. PubMed ID: 23183464
[TBL] [Abstract][Full Text] [Related]
23. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
Ohtsuka T; Yamazaki S
Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
[TBL] [Abstract][Full Text] [Related]
24. Parvovirus B19 infection after transplantation: a review of 98 cases.
Eid AJ; Brown RA; Patel R; Razonable RR
Clin Infect Dis; 2006 Jul; 43(1):40-8. PubMed ID: 16758416
[TBL] [Abstract][Full Text] [Related]
25. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
27. Parvovirus B19 infection mimicking acute myocardial infarction.
Kühl U; Pauschinger M; Bock T; Klingel K; Schwimmbeck CP; Seeberg B; Krautwurm L; Poller W; Schultheiss HP; Kandolf R
Circulation; 2003 Aug; 108(8):945-50. PubMed ID: 12925460
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
29. [Parvovirus B19 infection in patients with congenital blood coagulation disorders].
Aguilar Franco C; Lucía Cuesta JF; Ferrer Torres J; Omeñaca Teres M
Med Clin (Barc); 1997 May; 108(17):641-6. PubMed ID: 9312580
[TBL] [Abstract][Full Text] [Related]
30. Parvovirus B19 and in situ immune response in eczema and psoriasis skin lesions of patients from the Brazilian Amazon region.
Simões ACL; de Souza Aarão TL; de Sousa JR; Prudente DL; de Castro YG; Maneschy RB; Fuzii HT; Quaresma JAS
Microb Pathog; 2018 Apr; 117():27-31. PubMed ID: 29428424
[TBL] [Abstract][Full Text] [Related]
31. Parvovirus B19 infection in Chile: markers of infection and immunity in patients with clinical symptoms.
Larrañaga C; León O; Díaz P; Miranda M; Norambuena X; Pérez M; Gaggero A
J Med Virol; 2007 Dec; 79(12):1927-34. PubMed ID: 17935173
[TBL] [Abstract][Full Text] [Related]
32. Clinical and hematological study for Parvovirus b19 infection in children with acute leukemia.
Zaki ME; Ashray RE
Int J Lab Hematol; 2010 Apr; 32(2):159-66. PubMed ID: 19261033
[TBL] [Abstract][Full Text] [Related]
33. Parvovirus B19 infection in Taiwanese patients with hematological disorders.
Lee YM; Tsai WH; You JY; Ing-Tiau Kuo B; Liao PT; Ho CK; Hsu HC
J Med Virol; 2003 Dec; 71(4):605-9. PubMed ID: 14556276
[TBL] [Abstract][Full Text] [Related]
34. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.
Tzang BS; Tsai CC; Tsay GJ; Wang M; Sun YS; Hsu TC
Clin Chim Acta; 2009 Jul; 405(1-2):76-82. PubMed ID: 19362081
[TBL] [Abstract][Full Text] [Related]
35. Serological study of parvovirus B19 infection in women with recurrent spontaneous abortions.
Kishore J; Gupta I
Indian J Pathol Microbiol; 2006 Oct; 49(4):548-50. PubMed ID: 17183849
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of antibodies to parvovirus B 19 in Thailand.
Poovorawan Y; Theamboonlers A; Suandork P; Hirsch P
Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):422-4. PubMed ID: 11127352
[TBL] [Abstract][Full Text] [Related]
37. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection.
Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Duechting A; Kaiser H; Torresi J; Kandolf R; Bock CT
J Hepatol; 2006 Sep; 45(3):361-9. PubMed ID: 16684578
[TBL] [Abstract][Full Text] [Related]
38. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
Türk Dağı H; Ozdemir M; Baykan M; Baysal B
Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
[TBL] [Abstract][Full Text] [Related]
39. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
40. Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
Seishima M; Mizutani Y; Shibuya Y; Arakawa C
Dermatology; 2008; 216(4):341-6. PubMed ID: 18277075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
